Page last updated: 2024-08-24

1-octacosanol and Dyslipidemias

1-octacosanol has been researched along with Dyslipidemias in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Baralic, I; Ciric, MZ; Djordjevic, BI; Kotur-Stevuljevic, J; Markovic, S; Ostojic, M; Stankovic, I; Zivkovic, S	1

Trials

1 trial(s) available for 1-octacosanol and Dyslipidemias

Article	Year
Supplementation with Octacosanol Affects the Level of PCSK9 and Restore Its Physiologic Relation with LDL-C in Patients on Chronic Statin Therapy. Nutrients, 2021, Mar-10, Volume: 13, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Dyslipidemias; Fatty Alcohols; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Proprotein Convertase 9; Vitamin K 2; Vitamins	2021

Article

Year

Supplementation with Octacosanol Affects the Level of PCSK9 and Restore Its Physiologic Relation with LDL-C in Patients on Chronic Statin Therapy.

Nutrients, 2021, Mar-10, Volume: 13, Issue:3

Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Dyslipidemias; Fatty Alcohols; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Proprotein Convertase 9; Vitamin K 2; Vitamins

2021